Have a feature idea you'd love to see implemented? Let us know!

GLSI Greenwich LifeSciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: GLSI

Price (delayed)

$13.59

Market cap

$178.64M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.79

Enterprise value

$171.41M

Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a ...

Highlights
The equity fell by 45% YoY but it rose by 15% QoQ
The quick ratio has plunged by 85% YoY and by 62% from the previous quarter
The net income has contracted by 15% YoY and by 11% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://greenwichlifesciences.com
Peers: NVAX NVCR NBIX

Key stats

What are the main financial stats of GLSI
Market
Shares outstanding
13.14M
Market cap
$178.64M
Enterprise value
$171.41M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
29.79
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$10.22M
EBITDA
-$10.21M
Free cash flow
-$6.79M
Per share
EPS
-$0.79
Free cash flow per share
-$0.53
Book value per share
$0.46
Revenue per share
$0
TBVPS
$0.56
Balance sheet
Total assets
$7.23M
Total liabilities
$1.35M
Debt
$0
Equity
$5.88M
Working capital
$5.88M
Liquidity
Debt to equity
0
Current ratio
5.34
Quick ratio
5.34
Net debt/EBITDA
0.71
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-141.5%
Return on equity
-154%
Return on invested capital
N/A
Return on capital employed
-173.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GLSI stock price

How has the Greenwich LifeSciences stock price performed over time
Intraday
0%
1 week
-4.3%
1 month
-11.12%
1 year
65.73%
YTD
29.18%
QTD
-5.43%

Financial performance

How have Greenwich LifeSciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$10.54M
Net income
-$10.22M
Gross margin
N/A
Net margin
N/A
The net income has contracted by 15% YoY and by 11% from the previous quarter
The operating income has declined by 14% year-on-year and by 9% since the previous quarter

Growth

What is Greenwich LifeSciences's growth rate over time

Valuation

What is Greenwich LifeSciences stock price valuation
P/E
N/A
P/B
29.79
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GLSI's EPS is down by 13% year-on-year and by 10% since the previous quarter
GLSI's P/B is 69% higher than its 5-year quarterly average of 17.6
The equity fell by 45% YoY but it rose by 15% QoQ

Efficiency

How efficient is Greenwich LifeSciences business performance
The return on equity has dropped by 121% year-on-year and by 31% since the previous quarter
The ROA has shrunk by 107% YoY and by 25% QoQ

Dividends

What is GLSI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GLSI.

Financial health

How did Greenwich LifeSciences financials performed over time
The quick ratio has plunged by 85% YoY and by 62% from the previous quarter
The current ratio has plunged by 85% YoY and by 62% from the previous quarter
The company's debt is 100% lower than its equity
The equity fell by 45% YoY but it rose by 15% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.